Search research articles
Contact Us
Filters
Showing results (211-220 of 390) with videos related to
Page
of 39
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 11, 2024
Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis
John F Foley, Gilles Defer, Lana Zhovtis Ryerson, et al.
Therapeutic Advances in Neurological Disorders
|
February 28, 2024
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies
Helmut Butzkueven, Tomas Kalincik, Francesco Patti, et al.
Journal of Neuroimmunology
|
August 14, 2025
Neurotoxicity associated with chimeric antigen receptor T-cell therapy
Miriam Wronski, Robb Wesselingh, Christina Kazzi, et al.
Immunology and Cell Biology
|
June 14, 2024
Transcriptional network analysis of peripheral blood leukocyte subsets in multiple sclerosis identifies a pathogenic role for a cytotoxicity-associated gene network in myeloid cells
Margaret A Jordan, Melissa M Gresle, Adrian T Gemiarto, et al.
European Journal of Neurology
|
December 23, 2024
Longitudinal trajectories of digital upper limb biomarkers for multiple sclerosis
Yi Chao Foong, Daniel Merlo, Melissa Gresle, et al.
Multiple Sclerosis and Related Disorders
|
December 15, 2020
Fast and safe: Optimising multiple sclerosis infusions during COVID-19 pandemic
Louise Rath, Minh Viet Bui, Julian Ellis, et al.
Brain : a Journal of Neurology
|
February 4, 2026
Optimal strategies for treatment discontinuation in MOG antibody-associated disease
Wei Z Yeh, Anna Francis, Sarah Cooper, et al.
Neurology
|
May 31, 2015
Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS
Ludwig Kappos, Ernst-Wilhelm Radue, Giancarlo Comi, et al.
European Journal of Neurology
|
April 23, 2022
Psychometric deficits in autoimmune encephalitis: A retrospective study from the Australian Autoimmune Encephalitis Consortium
Sarah Griffith, Robb Wesselingh, James Broadley, et al.
Neurology
|
August 4, 2023
Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis
Vicki Maltby, Alexandre Xavier, Ewoud Ewing, et al.
Page
of 39
Search research articles
Search
Showing results (211-220 of 390) with videos related to
Sort By:
Page
of 39
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 11, 2024
Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis
John F Foley, Gilles Defer, Lana Zhovtis Ryerson, et al.
Therapeutic Advances in Neurological Disorders
|
February 28, 2024
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies
Helmut Butzkueven, Tomas Kalincik, Francesco Patti, et al.
Journal of Neuroimmunology
|
August 14, 2025
Neurotoxicity associated with chimeric antigen receptor T-cell therapy
Miriam Wronski, Robb Wesselingh, Christina Kazzi, et al.
Immunology and Cell Biology
|
June 14, 2024
Transcriptional network analysis of peripheral blood leukocyte subsets in multiple sclerosis identifies a pathogenic role for a cytotoxicity-associated gene network in myeloid cells
Margaret A Jordan, Melissa M Gresle, Adrian T Gemiarto, et al.
European Journal of Neurology
|
December 23, 2024
Longitudinal trajectories of digital upper limb biomarkers for multiple sclerosis
Yi Chao Foong, Daniel Merlo, Melissa Gresle, et al.
Multiple Sclerosis and Related Disorders
|
December 15, 2020
Fast and safe: Optimising multiple sclerosis infusions during COVID-19 pandemic
Louise Rath, Minh Viet Bui, Julian Ellis, et al.
Brain : a Journal of Neurology
|
February 4, 2026
Optimal strategies for treatment discontinuation in MOG antibody-associated disease
Wei Z Yeh, Anna Francis, Sarah Cooper, et al.
Neurology
|
May 31, 2015
Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS
Ludwig Kappos, Ernst-Wilhelm Radue, Giancarlo Comi, et al.
European Journal of Neurology
|
April 23, 2022
Psychometric deficits in autoimmune encephalitis: A retrospective study from the Australian Autoimmune Encephalitis Consortium
Sarah Griffith, Robb Wesselingh, James Broadley, et al.
Neurology
|
August 4, 2023
Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis
Vicki Maltby, Alexandre Xavier, Ewoud Ewing, et al.
Page
of 39